Evolved By Nature—a biotechnology company that creates renewably sourced biomolecule solutions to human health needs—announced that it has closed a $120 million Series C financing round, which was led by Senator Investment Group and Teachers' Venture Growth (TVG). GEN Edge sat down with co-founder and CEO Gregory Altman, PhD, to learn more about Evolved By Nature’s inception and evolution . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge